Form 4: AbbVie Director Glenn F. Tilton Reports Stock Award and Disposed Shares

Director Glenn F. Tilton reports acquisition of restricted stock units and disposition of common stock.

Summary

• Glenn F. Tilton, a director of AbbVie Inc., reported changes in beneficial ownership of AbbVie securities.
• On May 9, 2025, Tilton acquired 1,203 restricted stock units under the AbbVie Amended and Restated 2013 Incentive Stock Program.
• These restricted stock units will be paid in shares of AbbVie common stock on a one-to-one basis upon separation from service, death, or a change in control.
• Also on May 9, 2025, Tilton disposed of 350 shares of common stock held indirectly by his wife.
• Following these transactions, Tilton beneficially owns 51,564 shares of AbbVie common stock directly.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing, reporting stock transactions. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The restricted stock units will be paid out in AbbVie common stock upon the earlier of the director's separation from service, death, or a change in control, as defined in the AbbVie Amended and Restated 2013 Incentive Stock Program.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in company stock. It's a common practice for directors and officers to receive stock-based compensation, aligning their interests with those of shareholders.

Key Dates

Keywords

AbbVie, Director, Glenn F. Tilton, Form 4, Restricted Stock Units, Beneficial Ownership, Securities, Stock, ABBV